161 related articles for article (PubMed ID: 32590749)
1. Association between pentraxin-3 and the risk of preeclampsia: A meta-analysis.
Xiong Z; Wang X; Jiang S; Jin M; Chen W
Medicine (Baltimore); 2020 Jun; 99(26):e20744. PubMed ID: 32590749
[TBL] [Abstract][Full Text] [Related]
2. Pentraxin 3 is more accurate than C-reactive protein for Takayasu arteritis activity assessment: A systematic review and meta-analysis.
Wen X; Hou R; Xu K; Han Y; Hu J; Zhang Y; Su Y; Gao J; Zhang G; Zhang L
PLoS One; 2021; 16(2):e0245612. PubMed ID: 33529185
[TBL] [Abstract][Full Text] [Related]
3. Elevation of plasma levels of the long pentraxin 3 precedes preeclampsia in pregnant patients with type 1 diabetes.
Castiglioni MT; Scavini M; Cavallin R; Pasi F; Rosa S; Sabbadini MG; Rovere-Querini P
Autoimmunity; 2009 May; 42(4):296-8. PubMed ID: 19811281
[TBL] [Abstract][Full Text] [Related]
4. Increased Circulating Pentraxin 3 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis.
Guan SY; Chen Y; Shao M; Yang H; Xu W; Shuai Z; Zhao H; Zhao D; Pan F
Curr Pharm Des; 2022; 28(27):2260-2269. PubMed ID: 35708089
[TBL] [Abstract][Full Text] [Related]
5. Serum Pentraxin 3 is associated with signs of arterial alteration in women with preeclampsia.
Akhter T; Wikström AK; Larsson M; Larsson A; Wikström G; Naessen T
Int J Cardiol; 2017 Aug; 241():417-422. PubMed ID: 28377191
[TBL] [Abstract][Full Text] [Related]
6. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R; Casagrandi D; Livanos P; Tetteh A; Nicolaides KH
Prenat Diagn; 2009 Oct; 29(10):934-8. PubMed ID: 19565609
[TBL] [Abstract][Full Text] [Related]
7. [Expression of pentraxin-3 in placentas and its relationship with severe preeclampsia].
Zhou P; Luo X; Qi HB
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):347-50. PubMed ID: 22883522
[TBL] [Abstract][Full Text] [Related]
8. Estimation of asymmetric dimethylarginine (ADMA), placental growth factor (PLGF) and pentraxin 3 (PTX 3) in women with preeclampsia.
Garg P; Jaryal AK; Kachhawa G; Deepak KK; Kriplani A
Pregnancy Hypertens; 2018 Oct; 14():245-251. PubMed ID: 29548740
[TBL] [Abstract][Full Text] [Related]
9. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
[TBL] [Abstract][Full Text] [Related]
10. Association of pentraxin-3 with the severity of rheumatic mitral valve stenosis.
Polat N; Yildiz A; Alan S; Toprak N
Acta Cardiol; 2015 Aug; 70(4):409-13. PubMed ID: 26455242
[TBL] [Abstract][Full Text] [Related]
11. Circulating pentraxin-3 and preeclampsia: a meta-analysis of 17 case-control studies.
Liu Y; Li P
J Matern Fetal Neonatal Med; 2021 Nov; 34(22):3669-3677. PubMed ID: 31744359
[TBL] [Abstract][Full Text] [Related]
12. Circulating neutrophil gelatinase-associated lipocalin and preeclampsia: a meta-analysis.
Wei Y; Li L; Wang F; Fu L; Li Z; Hu Y
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2197100. PubMed ID: 37282560
[TBL] [Abstract][Full Text] [Related]
13. Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis.
Wang G; Jiang C; Fang J; Li Z; Cai H
Crit Care; 2022 Jun; 26(1):167. PubMed ID: 35676730
[TBL] [Abstract][Full Text] [Related]
14. IL‑1β‑induced pentraxin 3 inhibits the proliferation, invasion and cell cycle of trophoblasts in preeclampsia and is suppressed by IL‑1β antagonists.
Wang X; Zhang J; Ji J
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35137920
[TBL] [Abstract][Full Text] [Related]
15. Analyses of interleukin-6, presepsin and pentraxin-3 in the diagnosis and severity of late-onset preeclampsia.
Ovayolu A; Turksoy VA; Ovayolu G; Ozek MA; Dogan I; Karaman E
J Matern Fetal Neonatal Med; 2022 Jan; 35(2):299-307. PubMed ID: 31964198
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.
Weitoft T; Larsson A; Saxne T; Manivel VA; Lysholm J; Knight A; Rönnelid J
Scand J Rheumatol; 2017 Sep; 46(5):346-352. PubMed ID: 27973973
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy.
Galbiati S; Causarano V; Pinzani P; Francesca S; Orlando C; Smid M; Pasi F; Castiglioni MT; Cavoretto P; Rovere-Querini P; Pedroni S; Calza S; Ferrari M; Cremonesi L
Clin Chem Lab Med; 2010 Jun; 48(6):791-4. PubMed ID: 20374043
[TBL] [Abstract][Full Text] [Related]
18. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia.
Rovere-Querini P; Antonacci S; Dell'Antonio G; Angeli A; Almirante G; Cin ED; Valsecchi L; Lanzani C; Sabbadini MG; Doglioni C; Manfredi AA; Castiglioni MT
Obstet Gynecol; 2006 Jul; 108(1):148-55. PubMed ID: 16816069
[TBL] [Abstract][Full Text] [Related]
19. Association of prothrombin time, thrombin time and activated partial thromboplastin time levels with preeclampsia: a systematic review and meta-analysis.
Alemayehu E; Mohammed O; Belete MA; Mulatie Z; Debash H; Gedefie A; Weldehanna DG; Eshetu B; Shibabaw A; Tekele SG; Tilahun M; Ebrahim H
BMC Pregnancy Childbirth; 2024 May; 24(1):354. PubMed ID: 38741046
[TBL] [Abstract][Full Text] [Related]
20. [The role of long pentraxin 3, a new inflammatory mediator in inflammatory responses].
Okutani D
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):107-13. PubMed ID: 16819259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
